GIOVANNI B. FRISONIFaculty of Medicine & University Hospitals of Geneva
The past two years have seen an exponential increase of lay and scientific publications on the effects of the trillions small guests that each of us more or less willingly hosts even in the most secluded and intimate folds and holes of our body. High time, given that the power house of eukaryotic cells, mitochondria, are but ancient bacteria.
Reports have been published on the association of some bacterial strains in the guts (gut bacteria being by far the most represented microbial community) on human physiology (infant growth….) and somatic diseases (obesity, alcoholism, irritable-bowel syndrome and rheumatoid arthritis) and brain diseases (depression, autism, multiple sclerosis, Parkinson’s disease, Alzheimer’s disease).
Reports have multiplied of animal experiments showing that some natural features (resistance to infections and carcinogenic exposures) can be transferred from one animal to another by gut bacteria transfer. Not only, but it is increasingly clear that a number of environmental events can affect the bacterial composition of gut flora (diet, physical exercise, exposure to cold), that the animals with the modified version of the gut flora acquire specific physical and behavioural features (weight changes, sociability, motor impairments), and that such features can be transferred to non-exposed animals by gut bacteria transfer.
How much of these results is journalism hype and how much is sound science? How close (or how far for that matter) are we from gut flora manipulations in humans to protect from dreaded brain diseases?
The 3rd edition of this conference, which attracted 500 participants from Europe, will try and give an answer thanks to a panel of renowned national and international experts on the microbiota and the brain.
To update physicians and scientists on the latest discoveries on the role of the GMB in neuropsychiatric and neurodegenerative diseases.
To identify leads for microbiota-based interventions for brain diseases.
Tristan Bolmont, Annamaria Cattaneo, Jean François Démonet, Stephan Eliez, Taoufiq Harach, Gabriel Gold, Moira Marizzoni, Philippe Millet, Benjamin Tournier.
CME credits will be requested to: Association des médecins du canton de Genève, FAMH Medical Laboratories of Switzerland, Swiss Neurological Society, Swiss Professional Society of Geriatrics, Swiss Society of Gastroenterology, Swiss Society of General Internal Medicine, Swiss Society of Psychiatry and Psychotherapy.
We are grateful to the corporate and institutional sponsors that support the Human Microbiota & Brain Diseases – 3rd Edition.